nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—TTR—choroid plexus—intracranial aneurysm	0.213	0.263	CbGeAlD
Diclofenac—SLC22A8—choroid plexus—intracranial aneurysm	0.131	0.161	CbGeAlD
Diclofenac—KCNQ2—brainstem—intracranial aneurysm	0.0272	0.0336	CbGeAlD
Diclofenac—ASIC1—medulla oblongata—intracranial aneurysm	0.0259	0.032	CbGeAlD
Diclofenac—ASIC1—midbrain—intracranial aneurysm	0.0237	0.0292	CbGeAlD
Diclofenac—KCNQ3—medulla oblongata—intracranial aneurysm	0.0206	0.0254	CbGeAlD
Diclofenac—KCNQ3—midbrain—intracranial aneurysm	0.0189	0.0233	CbGeAlD
Diclofenac—ASIC1—cerebellum—intracranial aneurysm	0.0183	0.0226	CbGeAlD
Diclofenac—TTR—brainstem—intracranial aneurysm	0.0169	0.0209	CbGeAlD
Diclofenac—CXCL8—medulla oblongata—intracranial aneurysm	0.0155	0.0191	CbGeAlD
Diclofenac—ASIC1—brain—intracranial aneurysm	0.0149	0.0184	CbGeAlD
Diclofenac—KCNQ3—cerebellum—intracranial aneurysm	0.0146	0.018	CbGeAlD
Diclofenac—PTGS1—artery—intracranial aneurysm	0.0145	0.0178	CbGeAlD
Diclofenac—PLA2G2A—midbrain—intracranial aneurysm	0.0143	0.0176	CbGeAlD
Diclofenac—CXCL8—midbrain—intracranial aneurysm	0.0141	0.0174	CbGeAlD
Diclofenac—PTGS2—artery—intracranial aneurysm	0.0138	0.017	CbGeAlD
Diclofenac—KCNQ2—cerebellum—intracranial aneurysm	0.0134	0.0166	CbGeAlD
Diclofenac—SLCO1C1—midbrain—intracranial aneurysm	0.0121	0.0149	CbGeAlD
Diclofenac—KCNQ3—brain—intracranial aneurysm	0.0118	0.0146	CbGeAlD
Diclofenac—TTR—medulla oblongata—intracranial aneurysm	0.0118	0.0146	CbGeAlD
Diclofenac—CXCL8—cerebellum—intracranial aneurysm	0.0109	0.0135	CbGeAlD
Diclofenac—KCNQ2—brain—intracranial aneurysm	0.0109	0.0134	CbGeAlD
Diclofenac—TTR—midbrain—intracranial aneurysm	0.0108	0.0133	CbGeAlD
Diclofenac—PLA2G2A—brain—intracranial aneurysm	0.00898	0.0111	CbGeAlD
Diclofenac—CXCL8—brain—intracranial aneurysm	0.00889	0.011	CbGeAlD
Diclofenac—TTR—cerebellum—intracranial aneurysm	0.00834	0.0103	CbGeAlD
Diclofenac—SLCO1C1—brain—intracranial aneurysm	0.00758	0.00935	CbGeAlD
Diclofenac—ALOX5—cerebellum—intracranial aneurysm	0.00756	0.00933	CbGeAlD
Diclofenac—CXCR1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.00714	0.0377	CbGpPWpGaD
Diclofenac—SCN4A—brain—intracranial aneurysm	0.00697	0.0086	CbGeAlD
Diclofenac—SLC22A6—brain—intracranial aneurysm	0.00694	0.00856	CbGeAlD
Diclofenac—TTR—brain—intracranial aneurysm	0.00678	0.00836	CbGeAlD
Diclofenac—ALOX5—brain—intracranial aneurysm	0.00614	0.00758	CbGeAlD
Diclofenac—CXCR1—GPCRs, Other—EDNRA—intracranial aneurysm	0.00605	0.0319	CbGpPWpGaD
Diclofenac—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.00587	0.031	CbGpPWpGaD
Diclofenac—TTR—Amyloids—CST3—intracranial aneurysm	0.0055	0.029	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.00513	0.0271	CbGpPWpGaD
Diclofenac—CYP2E1—medulla oblongata—intracranial aneurysm	0.00446	0.0055	CbGeAlD
Diclofenac—CXCR1—Chemokine receptors bind chemokines—CCL2—intracranial aneurysm	0.0044	0.0232	CbGpPWpGaD
Diclofenac—ABCC1—cerebellum—intracranial aneurysm	0.0044	0.00542	CbGeAlD
Diclofenac—ALB—brain—intracranial aneurysm	0.00433	0.00534	CbGeAlD
Diclofenac—ABCC4—brain—intracranial aneurysm	0.00419	0.00517	CbGeAlD
Diclofenac—SLC22A8—brain—intracranial aneurysm	0.00415	0.00512	CbGeAlD
Diclofenac—PTGS2—medulla oblongata—intracranial aneurysm	0.0041	0.00506	CbGeAlD
Diclofenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.00394	0.0208	CbGpPWpGaD
Diclofenac—CXCL8—ATF4 activates genes—CCL2—intracranial aneurysm	0.00378	0.02	CbGpPWpGaD
Diclofenac—PTGS2—midbrain—intracranial aneurysm	0.00375	0.00463	CbGeAlD
Diclofenac—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.00366	0.0193	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—ELN—intracranial aneurysm	0.00366	0.0193	CbGpPWpGaD
Diclofenac—ABCC1—brain—intracranial aneurysm	0.00357	0.0044	CbGeAlD
Diclofenac—CXCL8—PERK regulates gene expression—CCL2—intracranial aneurysm	0.00346	0.0182	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00336	0.0177	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.00328	0.0173	CbGpPWpGaD
Diclofenac—CYP2E1—cerebellum—intracranial aneurysm	0.00315	0.00389	CbGeAlD
Diclofenac—CYP2C8—brain—intracranial aneurysm	0.00304	0.00375	CbGeAlD
Diclofenac—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.00291	0.0153	CbGpPWpGaD
Diclofenac—PTGS2—cerebellum—intracranial aneurysm	0.0029	0.00358	CbGeAlD
Diclofenac—CYP1A1—brain—intracranial aneurysm	0.00281	0.00346	CbGeAlD
Diclofenac—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—intracranial aneurysm	0.00277	0.0146	CbGpPWpGaD
Diclofenac—CYP2B6—brain—intracranial aneurysm	0.00273	0.00336	CbGeAlD
Diclofenac—CXCL8—Syndecan-2-mediated signaling events—MMP2—intracranial aneurysm	0.00269	0.0142	CbGpPWpGaD
Diclofenac—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—intracranial aneurysm	0.00263	0.0139	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00263	0.0139	CbGpPWpGaD
Diclofenac—CYP2E1—brain—intracranial aneurysm	0.00256	0.00316	CbGeAlD
Diclofenac—ABCB1—medulla oblongata—intracranial aneurysm	0.00254	0.00313	CbGeAlD
Diclofenac—PTGS1—brain—intracranial aneurysm	0.00247	0.00304	CbGeAlD
Diclofenac—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—intracranial aneurysm	0.00246	0.013	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—CTSS—intracranial aneurysm	0.00243	0.0128	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—STARD13—intracranial aneurysm	0.00238	0.0126	CbGpPWpGaD
Diclofenac—PTGS2—brain—intracranial aneurysm	0.00236	0.00291	CbGeAlD
Diclofenac—ABCB1—midbrain—intracranial aneurysm	0.00232	0.00286	CbGeAlD
Diclofenac—ABCC4—Platelet degranulation—TIMP1—intracranial aneurysm	0.00231	0.0122	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0023	0.0121	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00225	0.0119	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—CTSK—intracranial aneurysm	0.00223	0.0118	CbGpPWpGaD
Diclofenac—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.0022	0.0116	CbGpPWpGaD
Diclofenac—CXCL8—Chemokine receptors bind chemokines—CCL2—intracranial aneurysm	0.00198	0.0105	CbGpPWpGaD
Diclofenac—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—intracranial aneurysm	0.00198	0.0104	CbGpPWpGaD
Diclofenac—PLA2G2A—Spinal Cord Injury—CCL2—intracranial aneurysm	0.0019	0.01	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00185	0.00976	CbGpPWpGaD
Diclofenac—CXCL8—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00181	0.00956	CbGpPWpGaD
Diclofenac—ABCB1—cerebellum—intracranial aneurysm	0.00179	0.00221	CbGeAlD
Diclofenac—ALOX5—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00176	0.00929	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00172	0.00905	CbGpPWpGaD
Diclofenac—CXCL8—LPA receptor mediated events—MMP2—intracranial aneurysm	0.0017	0.00896	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00169	0.00893	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00169	0.00891	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.00166	0.00876	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00166	0.00874	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—STARD13—intracranial aneurysm	0.0016	0.00847	CbGpPWpGaD
Diclofenac—TTR—Disease—SLC25A16—intracranial aneurysm	0.00159	0.00838	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—SLC25A16—intracranial aneurysm	0.00155	0.00816	CbGpPWpGaD
Diclofenac—CXCL8—Unfolded Protein Response (UPR)—CCL2—intracranial aneurysm	0.00152	0.00804	CbGpPWpGaD
Diclofenac—CXCL8—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00152	0.008	CbGpPWpGaD
Diclofenac—ABCB1—brain—intracranial aneurysm	0.00146	0.0018	CbGeAlD
Diclofenac—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—intracranial aneurysm	0.00142	0.00749	CbGpPWpGaD
Diclofenac—PLA2G2A—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00136	0.00716	CbGpPWpGaD
Diclofenac—CXCL8—LPA receptor mediated events—MMP9—intracranial aneurysm	0.00128	0.00673	CbGpPWpGaD
Diclofenac—CXCL8—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00119	0.00628	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.00119	0.00627	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—SLC25A16—intracranial aneurysm	0.00114	0.00599	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00111	0.00586	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00109	0.00577	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STARD13—intracranial aneurysm	0.00108	0.00568	CbGpPWpGaD
Diclofenac—UGT2B7—NRF2 pathway—AGER—intracranial aneurysm	0.00107	0.00565	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—intracranial aneurysm	0.00107	0.00563	CbGpPWpGaD
Diclofenac—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.00105	0.00552	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00103	0.00541	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—ASAH1—intracranial aneurysm	0.00102	0.00541	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00102	0.00537	CbGpPWpGaD
Diclofenac—ABCC4—NRF2 pathway—AGER—intracranial aneurysm	0.00101	0.00532	CbGpPWpGaD
Diclofenac—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.000996	0.00526	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000969	0.00512	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00088	0.00465	CbGpPWpGaD
Diclofenac—UGT1A1—NRF2 pathway—AGER—intracranial aneurysm	0.00087	0.00459	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000866	0.00457	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—MMP2—intracranial aneurysm	0.000848	0.00448	CbGpPWpGaD
Diclofenac—KCNQ2—Axon guidance—MMP2—intracranial aneurysm	0.000848	0.00448	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—CCL2—intracranial aneurysm	0.000845	0.00446	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—MMP2—intracranial aneurysm	0.000814	0.0043	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000805	0.00425	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000782	0.00413	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—EDNRA—intracranial aneurysm	0.000774	0.00409	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—SLC25A16—intracranial aneurysm	0.000764	0.00403	CbGpPWpGaD
Diclofenac—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.000763	0.00403	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.000758	0.004	CbGpPWpGaD
Diclofenac—ABCC4—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.000756	0.00399	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ASAH1—intracranial aneurysm	0.000752	0.00397	CbGpPWpGaD
Diclofenac—CXCL8—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.000747	0.00394	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—SLC25A16—intracranial aneurysm	0.000743	0.00392	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000732	0.00386	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SLC25A16—intracranial aneurysm	0.000695	0.00367	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—MMP2—intracranial aneurysm	0.000643	0.00339	CbGpPWpGaD
Diclofenac—KCNQ2—Axon guidance—MMP9—intracranial aneurysm	0.000637	0.00336	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—MMP9—intracranial aneurysm	0.000637	0.00336	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.000617	0.00326	CbGpPWpGaD
Diclofenac—TTR—Extracellular matrix organization—MMP9—intracranial aneurysm	0.000612	0.00323	CbGpPWpGaD
Diclofenac—TTR—Disease—CST3—intracranial aneurysm	0.000609	0.00321	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.000606	0.0032	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—MMP2—intracranial aneurysm	0.000605	0.00319	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—MMP2—intracranial aneurysm	0.000605	0.00319	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—SLC25A16—intracranial aneurysm	0.000604	0.00319	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—SLC25A16—intracranial aneurysm	0.000582	0.00307	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000581	0.00307	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000571	0.00301	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NCF1—intracranial aneurysm	0.000551	0.00291	CbGpPWpGaD
Diclofenac—TTR—Disease—NCF1—intracranial aneurysm	0.000529	0.00279	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TIMP1—intracranial aneurysm	0.000528	0.00279	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00052	0.00274	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000516	0.00272	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ASAH1—intracranial aneurysm	0.000506	0.00267	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.000501	0.00264	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ASAH1—intracranial aneurysm	0.000492	0.0026	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	0.000492	0.0026	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00049	0.00259	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—MMP9—intracranial aneurysm	0.000483	0.00255	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.000479	0.00253	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000473	0.0025	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00047	0.00248	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.000467	0.00246	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.000464	0.00245	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—MMP2—intracranial aneurysm	0.000459	0.00242	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—MMP9—intracranial aneurysm	0.000455	0.0024	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—MMP9—intracranial aneurysm	0.000455	0.0024	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000438	0.00231	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000434	0.00229	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000422	0.00223	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ASAH1—intracranial aneurysm	0.0004	0.00211	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000397	0.0021	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.000391	0.00206	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ASAH1—intracranial aneurysm	0.000386	0.00204	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000385	0.00203	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—CCL2—intracranial aneurysm	0.000382	0.00201	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—SLC25A16—intracranial aneurysm	0.000376	0.00198	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NCF1—intracranial aneurysm	0.000371	0.00196	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—SLC25A16—intracranial aneurysm	0.000368	0.00194	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EDNRA—intracranial aneurysm	0.00035	0.00185	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SLC25A16—intracranial aneurysm	0.000347	0.00183	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—MMP9—intracranial aneurysm	0.000345	0.00182	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.000343	0.00181	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000329	0.00174	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ASAH1—intracranial aneurysm	0.000326	0.00172	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.000318	0.00168	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.000316	0.00167	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC25A16—intracranial aneurysm	0.000284	0.0015	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000277	0.00146	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—CCL2—intracranial aneurysm	0.000268	0.00142	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CST3—intracranial aneurysm	0.000266	0.00141	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.000259	0.00137	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.000259	0.00137	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CCL2—intracranial aneurysm	0.000256	0.00135	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—MMP2—intracranial aneurysm	0.000255	0.00135	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ASAH1—intracranial aneurysm	0.000249	0.00131	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NCF1—intracranial aneurysm	0.000249	0.00131	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ASAH1—intracranial aneurysm	0.000244	0.00129	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.000239	0.00126	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NOS3—intracranial aneurysm	0.000238	0.00126	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EDNRA—intracranial aneurysm	0.000235	0.00124	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NCF1—intracranial aneurysm	0.000232	0.00122	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ASAH1—intracranial aneurysm	0.00023	0.00121	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NOS3—intracranial aneurysm	0.000228	0.00121	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	0.000221	0.00117	CbGpPWpGaD
Diclofenac—TTR—Disease—NOS3—intracranial aneurysm	0.000219	0.00116	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—NOS3—intracranial aneurysm	0.000214	0.00113	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.000211	0.00111	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000209	0.00111	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—CCL2—intracranial aneurysm	0.000196	0.00103	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ASAH1—intracranial aneurysm	0.000188	0.000992	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000183	0.000968	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MMP9—intracranial aneurysm	0.000183	0.000967	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CST3—intracranial aneurysm	0.000179	0.000944	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CCL2—intracranial aneurysm	0.000172	0.00091	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	0.000171	0.000905	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000171	0.000901	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—NOS3—intracranial aneurysm	0.000157	0.000828	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NCF1—intracranial aneurysm	0.000155	0.000821	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NOS3—intracranial aneurysm	0.000154	0.000811	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	0.000146	0.000773	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MMP9—intracranial aneurysm	0.000123	0.000651	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCL2—intracranial aneurysm	0.000116	0.00061	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000113	0.000597	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NOS3—intracranial aneurysm	0.000108	0.000569	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—NOS3—intracranial aneurysm	0.000106	0.000557	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NOS3—intracranial aneurysm	0.000103	0.000544	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—NOS3—intracranial aneurysm	0.000103	0.000542	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOS3—intracranial aneurysm	9.61e-05	0.000507	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—NOS3—intracranial aneurysm	8.35e-05	0.00044	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—intracranial aneurysm	8.27e-05	0.000437	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—NOS3—intracranial aneurysm	8.05e-05	0.000425	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—NOS3—intracranial aneurysm	6.8e-05	0.000359	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS3—intracranial aneurysm	6.45e-05	0.00034	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NOS3—intracranial aneurysm	5.4e-05	0.000285	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NOS3—intracranial aneurysm	5.19e-05	0.000274	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NOS3—intracranial aneurysm	5.08e-05	0.000268	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NOS3—intracranial aneurysm	4.79e-05	0.000253	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NOS3—intracranial aneurysm	4.39e-05	0.000232	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NOS3—intracranial aneurysm	4.37e-05	0.000231	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NOS3—intracranial aneurysm	3.92e-05	0.000207	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NOS3—intracranial aneurysm	3.83e-05	0.000202	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NOS3—intracranial aneurysm	3.58e-05	0.000189	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NOS3—intracranial aneurysm	3.06e-05	0.000161	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NOS3—intracranial aneurysm	2.36e-05	0.000124	CbGpPWpGaD
